doi: Luz, Y., Calvi, I.P., Marques, I.R., Cruz, S.A., Messias, E., Emanuel, P., Azevedo, H., Cardoso, R., Moura, F.A
Pujadas G, Baggio LL, Kaur KD, McLean BA, Cao X, Drucker DJ (2022) Genetic disruption of the Gipr in Apoe(-/-) mice promotes atherosclerosis
Earlier in the year, Novos semaglutide-based GLP-1 drugs (including Ozempic and Wegovy) were listed among the drugs subject to Medicare pricing negotiations, with the negotiated price dropping 71% for Medicare beneficiaries, set to take effect in 2027
Nothing urgent, but enough to make me think harder about what I was doing for my health
And for comprehensive fat loss context, our peptides for fat loss page covers the full landscape of peptide options beyond GLP-1 alone
Endocrinology 156 , 847857 (2015)